Does ICOSAPENT Cause Hypertriglyceridaemia? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hypertriglyceridaemia have been filed in association with ICOSAPENT. This represents 13.0% of all adverse event reports for ICOSAPENT.
16
Reports of Hypertriglyceridaemia with ICOSAPENT
13.0%
of all ICOSAPENT reports
1
Deaths
16
Hospitalizations
How Dangerous Is Hypertriglyceridaemia From ICOSAPENT?
Of the 16 reports, 1 (6.3%) resulted in death, 16 (100.0%) required hospitalization.
Is Hypertriglyceridaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ICOSAPENT. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does ICOSAPENT Cause?
Hepatotoxicity (36)
Drug-induced liver injury (35)
Hepatic cirrhosis (33)
Hepatic encephalopathy (33)
Hepatic necrosis (33)
Drug interaction (29)
Drug ineffective (24)
Myocardial infarction (15)
Coronary artery disease (12)
Acute myocardial infarction (9)
What Other Drugs Cause Hypertriglyceridaemia?
PEGASPARGASE (399)
VINCRISTINE (373)
METHOTREXATE (372)
DEXAMETHASONE (358)
CYTARABINE (244)
CYCLOPHOSPHAMIDE (191)
QUETIAPINE (181)
MERCAPTOPURINE (176)
PREDNISONE (161)
DAUNORUBICIN (143)
Which ICOSAPENT Alternatives Have Lower Hypertriglyceridaemia Risk?
ICOSAPENT vs ICOSAPENT ETHYL
ICOSAPENT vs IDARUBICIN
ICOSAPENT vs IDARUCIZUMAB
ICOSAPENT vs IDECABTAGENE VICLEUCEL
ICOSAPENT vs IDELALISIB